iDEL Therapeutics GmbH | $10,381,635 | (Mar 18, 2026)
Surf AI(1) | $57,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
Certified by Founder
Lodge
Biorithm
start up
Singapore
- Singapore
- 19/12/2023
- Series A
- $3,500,000
By leading a new standard of maternity care, Biorithm aims to end preventable pregnancy complications & stillbirth through predictive and precision medicine.
Forging new frontiers in women's health and pregnancy care to improve outcomes globally, we have developed cutting-edge analytic software together with medical-grade wearables for accurate monitoring of a wide range of pregnancy data.
Founded by doctors & engineers, Biorithm is a medical technology company, spun off from Nanyang Technological University Singapore (NTU).
- Industry Medical Device
- Website https://www.bio-rithm.com/
- LinkedIn https://www.linkedin.com/company/biorithm/about/
Related People
Amrish NairFounder
Singapore -
Singapore
Signal processing engineer with a focus on sparse sampling and biomedical applications. Experience with academia and interdisciplinary research with clinicians.
Quorus | $5,000,000 | (Mar 18, 2026)
BambooBox | $6,600,000 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
SEQUENTIAL | $3,500,000 | (Mar 18, 2026)
Standard Template Labs | $49,000,000 | (Mar 18, 2026)
Tenkara | $7,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
Malama Health | $9,200,000 | (Mar 17, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)